186448-86-2

Upstream product

• 164714-14-1 {(1R,2R,4S)-4-[(2R,3S)-4-{2-[(E)-(R)-3-((R)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-1-methyl-but-2-enyl]-[1,3]dithian-2-yl}-3-(4-methoxy-benzyloxy)-2-methyl-butyl]-2-methoxy-cyclohexyloxy}-triisopropyl-silane 
• 157837-39-3 Methanesulfonic acid (1S,2R)-1-(tert-butyl-diphenyl-silanyloxymethyl)-3-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-2-methyl-propyl ester 
• 186448-80-6 (E)-(2R,5R)-5-{2-[(2S,3R)-2-(4-Methoxy-benzyloxy)-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butyl]-[1,3]dithian-2-yl}-3-methyl-hex-3-ene-1,2-diol 
• 157837-32-6 (2S,3R)-1-(tert-Butyl-diphenyl-silanyloxy)-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butan-2-ol 
• 186448-78-2 (R)-2-Benzenesulfonyl-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-3-[1,3]dithian-2-yl-butan-1-one 
• 157837-42-8 Trifluoro-methanesulfonic acid (Z)-(R)-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-3-[1,3]dithian-2-yl-but-1-enyl ester 
• 157837-41-7 {(1R,2R,4S)-4-[(2R,3R)-4-Iodo-3-(4-methoxy-benzyloxy)-2-methyl-butyl]-2-methoxy-cyclohexyloxy}-triisopropyl-silane 
• 157837-40-6 (2R,3R)-1-Iodo-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butan-2-ol 
• 157837-35-9 (R)-1-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-3-[1,3]dithian-2-yl-butan-1-one 
• 157837-43-9 (R)-4-((E)-(R)-3-[1,3]Dithian-2-yl-1-methyl-but-1-enyl)-2,2-dimethyl-[1,3]dioxolane 
• 143619-00-5 Triisopropyl-[(1R,2R,4S)-2-methoxy-4-((R)-(R)-2-oxiranyl-propyl)-cyclohexyloxy]-silane 
• 89238-99-3 O-(4-methoxybenzyl)-trichloroacetimidate 
• 127258-23-5 (1R,2R,4R)-4-<(phenylsulfonyl)methyl>-2-methoxy-1-<oxy>cyclohexane 
• 186448-81-7 Toluene-4-sulfonic acid (E)-(2R,5R)-2-hydroxy-5-{2-[(2S,3R)-2-(4-methoxy-benzyloxy)-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butyl]-[1,3]dithian-2-yl}-3-methyl-hex-3-enyl ester 

Downstream Products

• 186449-18-3 C₅₇H₁₀₀Br₂O₅S₄Si₂ 
• 164592-60-3 C₅₈H₁₀₆O₇S₄Si₂ 
• 164592-80-7 C₅₆H₁₀₀O₆S₄Si₂ 
• 164592-82-9 C₅₇H₁₀₀O₅S₄Si₂ 
• 164592-84-1 (2S,3R)-1-(2-{(E)-(1R,4S)-4-(tert-Butyl-dimethyl-silanyloxy)-5-[2-((1R,3S)-1,3-dimethyl-pent-4-ynyl)-[1,3]dithian-2-yl]-1,3-dimethyl-pent-2-enyl}-[1,3]dithian-2-yl)-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butan-2-ol 
• 164592-86-3 (E)-(2R,3S,6R,9S,12R,14S)-9-(tert-Butyl-dimethyl-silanyloxy)-3-hydroxy-1-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-2,6,8,12,14-pentamethyl-hexadec-7-en-15-yne-5,11-dione 
• 164592-59-0 (E)-(2S,5R)-1-[2-((1R,3S)-4,4-Dimethoxy-1,3-dimethyl-butyl)-[1,3]dithian-2-yl]-5-{2-[(2S,3R)-2-(4-methoxy-benzyloxy)-4-((1S,3R,4R)-3-methoxy-4-triisopropylsilanyloxy-cyclohexyl)-3-methyl-butyl]-[1,3]dithian-2-yl}-3-methyl-hex-3-en-2-ol 

Relevant academic research and scientific papers

A unified total synthesis of the immunomodulators (-)-rapamycin and (-)-27-demethoxyrapamycin: Construction of the C(21-42) perimeters

A total synthesis of the potent, naturally occurring immunomodulators (-)-rapamycin (1) and (-)-27-demethoxyrapamycin (2) has been achieved via a unified, highly convergent synthetic strategy. Both targets were elaborated from common building blocks A-E,